North America Drug Modelling Software Market Insights, Trends Sales, Supply, Demand 2020 to 2027

Publisher: The Insight Partners

According to our new market research study on “North America Drug Modelling Software Market to 2027 – Regional Analysis and Forecast – by Type, and Application” the market is expected to reach US$ 4,588.87 million by 2027 from US$  2,468.17 million in 2019; it is estimated to grow at a CAGR of 8.4% from 2020 to 2027. The report provides trends prevailing in the North America drug modelling software market and the factors driving the market growth along with those hindering it.

In 2019, the software segment accounted for the highest share of the market. Also, the same segment is estimated to grow at the highest CAGR in the forecast period. Growth of this segment is attributed to the growing demand for effective therapeutics and increase in drug discovery efforts of various biologics across a wide range of therapeutics. In addition, strategic activities by service providers such as collaborations, product advancement, and product launch in order to expediate drug discovery timeline are further accelerating the growth of the market.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.theinsightpartners.com/sample/TIPRE00013990/

Company Profiles

• Crown Bioscience Inc (JSR life science)
• Chemical Computing Group ULC
• Nimbus Therapeutics
• Schrödinger, Inc
• Leadscope, Inc (Instem)

The growth of the North America drug modelling software market is mainly attributed to the rapid integration of AI for the drug discovery, increasing preference for personalized medicine, high R&D spending for novel therapeutic applications and presence of major market players. However, the lack of data standardization is the major factor hindering the market growth in North America.

Crown Bioscience Inc (JSR life science); Chemical Computing Group ULC; Nimbus Therapeutics; Leadscope, Inc (Instem); and Schrödinger, Inc are among the leading companies operating in the North America drug modelling software market.

NORTH AMERICA DRUG MODELLING SOFTWARE MARKET SEGMENTATION

By Product Type

• Database
• Software
• Others

By Application

• Drug Discovery and Development
• Computational Physiological Medicine
• Disease Modeling
• Medical Imaging
• Predictive Analysis of Drug Targets
• Simulation Software
• Cellular Simulation
• Others

By Country

• US
• Canada
• Mexico 

Purchase a copy of this research report @ https://www.theinsightpartners.com/buy/TIPRE00013990/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com